Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02985957
Brief Title: Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

First Submitted : November 22, 2016
First Submitted that Met QC Criteria : December 5, 2016
First Posted : December 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 10, 2020
Last Update Posted : January 13, 2020